Table of Contents
| Myth | Reality |
|---|---|
| “I might get a placebo instead of real treatment.” | Many diabetes trials use an “add-on” design where all participants receive standard care plus either the experimental drug or a placebo. Placebo-controlled trials are uncommon for life-threatening conditions unless no approved therapy exists. Moreover, participants are always informed of the possibility during consent. |
| “Clinical trials are only for people who have exhausted all other options.” | Trials are open to people at various stages of disease—from newly diagnosed to those with long-standing diabetes. Some studies specifically seek participants with well-controlled diabetes to test preventive strategies. |
| “It’s too risky to try something experimental.” | All trials undergo rigorous safety review. Phase 1 trials involve healthy volunteers to assess safety first. Researchers carefully balance potential risks against the possibility of benefit, and you can withdraw at any time. |
| “I’ll have to travel far and spend a lot of time.” | Many studies have multiple sites, including local hospitals and clinics. Telehealth visits are increasingly common, reducing the need for travel. Study coordinators can help arrange logistics. |